dr francesco pampaloni lsfm4life

LSFM4LIFE seminar to T1D patients by Dr Francesco Pampaloni

On Sunday 17 September 2017, Dr. Francesco Pampaloni, the scientific manager of the LSFM4LIFE project, gave a seminar to Type 1 Diabetes patients and their families about our project: “An achievable future for Type 1 Diabetes cellular therapy”. The seminar was organised as a part of Summer festival of the ATBGD (Associazione Toscana Bambini e Giovani con Diabete – Tuscan Association for Diabetic Children …

featured_Image_Dr_Kourosh_Saeb_Parsy_Transplantation

Lecture on organ transplantation by Dr Kourosh Saeb-Parsy

Last week, one of the partners of LSFM4LIFE project, Dr. Kourosh Saeb-Parsy, from the Department of Surgery at Cambridge University, gave a video-lecture on organ transplantation. The concept of Chimera Dr Kourosh Saeb-Parsy is a University Lecturer and Consultant Transplant Surgeon at the University of Cambridge. His role in LSFM4LIFE project is the provision of pancreas tissue from human organs …

STARBIOS2-FEATURES IMAGE - BLOG (3)

LSFM4LIFE featured on Superquark!

Last June a very famous Italian TV channel, RAI (Radiotelevisione Italiana) interviewed one of LSFM4LIFE’s partner to talk about Type 1 Diabetes (T1D) and the importance of the research around that disease, in order to spare affected people from lifelong insulin therapy. What is RAI TV channel? RAI channel is the national public broadcasting company in Italy. It features a …

Capture 3

Organoids is a bet on which a lot of people invested – Organoidi, una scommessa bagnata da un diluvio di investimenti

Published in pagina99, an Italian online and offline. Written by Roberta Villa on June 02, 2016 The Italian online and printed magazine, Pagina99, has dedicated in June 2016, an article on organoids and more specifically on scientific institutes who are working hard to improve biomedical research. The article mentions the LSFLM4LIFE project and explains it shortly. The author of the article quotes Lorenza Lazzari, head of …

TALKS (7)

Dr. Pampaloni visits paediatric hospitals to talk about new T1D solutions

At the beginning of March 2017, Dr. Francesco Pampaloni, of the Goethe University Frankfurt, the LSFM4LIFE coordinator, visited three of the biggest paediatric hospitals and clinical research centers in Italy. The purpose of his venue was to inform paediatricians of the solutions LSFM4LIFE aims to bring to T1D patients using cellular therapy with adult stem cells. Hospitals visits Dr. Pampaloni started his visits by going …

TALKS (4)

Cellular therapy of T1D with adult stem cells: the challenge of the LSFM4LIFE project

Dr. Francesco Pampaloni, scientific manager and coordinator of the LSFM4LIFE project at Goethe University in Frankfurt, will be performing three talks in March 2017 about cellular therapy for type 1 diabetes (T1D). All those presentations will take place in Italy, in different Hospitals. In these talks Dr. Pampaloni will further explain further the goal of the LSFM4LIFE project to medical doctors …

A step forward

A Step Forward: Optimised organoid culture

The Huch lab at the Gurdon Institute, University of Cambridge, works with liver and pancreas organoids derived from murine and human samples. The cultures, which were established by Meritxell Huch while at the Clevers lab at the Hubrecht Institute in Utrecht, model in vitro the proliferative response of the ductal population in the adult liver and pancreas (Huch et al, …

PhD Corner

PhD Corner: Interview of L.HOF and T.MORETH

    Lotta HOF is a PhD from Goethe University, in Frankfurt am Main. She studied molecular biology and molecular genetics in Chironomidae before specializing in “Cell Biology and Physiology” in master’s. Currently, she is working with the group of Prof. Stelzer on the LSFM4Life project, more precisely on the physical characterization of the pancreatic organoids in order to provide …

Latest News

Latest News: First year recap on progress in organoid culture technology

The LSFM4LIFE project has been challenging but rewarding from the very beginning. We have successfully transfered the organoid technology from the laboratories in Cambridge University to the labs of three partners, who attended a week-long training course in Meritxell Huch’s laboratory in Cambridge in order to learn about the culture of pancreas organoids in Matrigel. Thanks to those actions, those three …

MiniLSFM4LIFEteam

New EU project addresses diabetes with pancreas organoids

The innovations introduced by LSFM4LIFE strengthen the leadership of Europe in the field of advanced therapies and, in particular, in cell-based therapies. LSFM4LIFE project uses hPO as a new cell-based therapy for Type 1 Diabetes The goal of the new european project LSFM4LIFE is the production of long-term renewing pancreas organoids for the cellular therapy of type 1 diabetes. The cause of this type …